NCT05514327
- Conditions
- Bridging Therapy, CAR-T, Diffuse Large B Cell Lymphoma, +12 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,249 public trials
217 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
NCT04830137
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
- Locations
-
- City of Hope Duarte, California, United States
- University of California Irvine Orange, California, United States
- University of California San Francisco Medical Center San Francisco, California, United States
- Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
Recruiting
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
NCT06026319
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Grade 3b Follicular Lymphoma, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT07473167
- Conditions
- Diffuse Large B-Cell Lymphoma (DLBCL), Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma (HGBL), +14 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT05256641
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, High-grade B-cell Lymphoma, +12 more
- Locations
-
- UCLA / Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- University of Oklahoma Oklahoma City, Oklahoma, United States
NCT07042438
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
NCT05800366
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- University of Miami Sylvester Cancer Center Miami, Florida, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
NCT06486051
- Conditions
- Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Christchurch Hospital Christchurch, Christchurch Central, New Zealand
- Wellington Hospital Newtown, Wellington Region, New Zealand
- Auckland City Hospital Auckland, New Zealand
NCT04231877
- Conditions
- ALK-Positive Large B-Cell Lymphoma, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT07443514
- Conditions
- Chemically-Induced Disorders, Chemotherapy-Related Cognitive Impairment, Cognition Disorders, +16 more
- Locations
-
- Institute of Oncology Ljubljana Ljubljana, Slovenia